Status:
COMPLETED
Salicylic Acid Wart Patch for the Treatment of Common Warts and Plantar Warts
Lead Sponsor:
Langsteiner sp. z o.o.
Conditions:
Common Warts
Plantar Warts
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Common and plantar warts are a type of skin lesion caused by infection with the human papilloma virus. The incidence of warts is relatively high, with an estimated few to several per cent of the adult...
Eligibility Criteria
Inclusion
- giving consent to participate in the clinical trial (consent of the minor's guardian where applicable);
- presence of at least 1 wart (common/plantar) on the body, with a lesion up to 1 cm in diameter;
- age, at least 6 years.
Exclusion
- failure to meet at least 1 inclusion criterion;
- the patient has a known hypersensitivity to salicylic acid, salicylates or any other component of the patch;
- patients with renal impairment (renal failure);
- patients with skin conditions (e.g. inflammation, wounds, eczema) at the site of application,
- patients concurrently using other topical treatments in the area of the wart,
- diabetic patients.
Key Trial Info
Start Date :
May 19 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06958237
Start Date
May 19 2025
End Date
September 5 2025
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Kowalska Clinic
Miechów, Lesser Poland Voivodeship, Poland, 32-200